Antidiabetic activities of oligosaccharides of Ophiopogonis japonicus in experimental type 2 diabetic rats

被引：42

作者：

Li, Pei-Bo ^{[1
]}

Lin, Wan-Ling ^{[1
]}

Wang, Yong-Gang ^{[1
]}

Peng, Wei ^{[1
]}

Cai, Xue-Ying ^{[1
]}

Su, Wei-Wei ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangdong Key Lab Plant Resources,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2012年 / 51卷 / 05期

关键词：

Oligosaccharides of Ophiopogonis japonicus; Antidiabetic effect; Type 2 diabetes mellitus; GLYCOGEN-SYNTHASE ACTIVITY; INSULIN-RESISTANCE; PLASMA-GLUCOSE; DIET; GLUCAGON; POLYSACCHARIDE; STREPTOZOTOCIN; MAINTENANCE; PROTEINURIA; EXPRESSION;

D O I：

10.1016/j.ijbiomac.2012.07.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The aim of the present study is to investigate the antidiabetic properties of oligosaccharides of Ophiopogonis japonicus (OOJ) in experimental type 2 diabetic rats. OOJ was administered orally in doses of 225 and 450 mg/kg body weight to high-fat diet and low-dose streptozotocin (STZ)-induced type 2 diabetic rats for 3 weeks. The results showed that OOJ treatment could increase body weight, decrease organ related weights of liver and kidney, reduce fasting blood glucose level, and improve oral glucose tolerance in diabetic rats. Moreover, increased glycogen content in liver and skeletal muscle, reduced urinary protein excretion, higher hepatic GCK enzyme activity, lower hepatic PEPCK enzyme activity, enhanced GLP-1 level, decreased glucagon level and alleviated histopathological changes of pancreas occurred in OOJ-treated diabetic rats by comparison with untreated diabetic rats. This study demonstrates, for the first time to our knowledge, that OOJ exerts remarkable antidiabetic effect in experimental type 2 diabetes mellitus, thus justifying its traditional usage. (C) 2012 Elsevier B.V. All rights reserved.

引用

页码：749 / 755

页数：7

共 43 条

[11] MEDICINE Diabetes in India
Diamond, Jared
[J]. NATURE, 2011, 469 (7331) : 478 - 479
[12] Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions
Fyfe, M. C. T.
White, J. R.
Taylor, A.
Chatfield, R.
Wargent, E.
Printz, R. L.
Sulpice, T.
McCormack, J. G.
Procter, M. J.
Reynet, C.
Widdowson, P. S.
Wong-Kai-In, P.
[J]. DIABETOLOGIA, 2007, 50 (06) : 1277 - 1287
[13] Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes
Gautier, JF
Fetita, S
Sobngwi, E
Salaün-Martin, C
[J]. DIABETES & METABOLISM, 2005, 31 (03) : 233 - 242
[14] Fasting plasma glucose and diabetes diagnosis
Giavarina, D
Dorizzi, RM
Moghetti, P
[J]. CLINICA CHIMICA ACTA, 1996, 252 (02) : 209 - 213
[15] Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm
Green, J.
Feinglos, M.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 : 3 - 11
[16] Female rats do not exhibit free fatty acid-induced insulin resistance
Hevener, A
Reichart, D
Janez, A
Olefsky, J
[J]. DIABETES, 2002, 51 (06) : 1907 - 1912
[17] The physiology of glucagon-like peptide 1
Holst, Jens Juul
[J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (04) : 1409 - 1439
[18] Antidiabetic properties of purified polysaccharide from Hedysarum polybotrys
Hu, Fangdi
Li, Xiaodong
Zhao, Lianggong
Feng, Shilan
Wang, Chunming
[J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2010, 88 (01) : 64 - 72
[19] Type 2 diabetes mellitus-Its global prevalence and therapeutic strategies
Jain, Shelesh
Saraf, Swarnlata
[J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2010, 4 (01) : 48 - 56
[20] THE IMPACT OF METFORMIN THERAPY ON HEPATIC GLUCOSE-PRODUCTION AND SKELETAL-MUSCLE GLYCOGEN-SYNTHASE ACTIVITY IN OVERWEIGHT TYPE-II DIABETIC-PATIENTS
JOHNSON, AB
WEBSTER, JM
SUM, CF
HESELTINE, L
ARGYRAKI, M
COOPER, BG
TAYLOR, R
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (09): : 1217 - 1222

← 1 2 3 4 5 →